Abstract
Small bowel malignancies are rare. The aims of this study were to evaluate the outcomes associated with surgical therapy for small bowel cancers and to define prognostic factors. The medical records of 96 consecutive patients with primary small bowel cancer (excluding lymphoma) treated at our institution over a 20 year period were reviewed. Survival was analyzed using the Kaplan-Meier method (mean follow-up period 57 months). Mean patient age was 56 years, and 58% of patients were male. Sixty percent of patients had an adenocarcinoma, 21% had a sarcoma, and 19% had a carcinoid tumor. The percentages of patients who underwent complete (curative) resection were 51%, 90%, and 50% for those with adenocarcinoma, sarcoma, and carcinoid tumor, respectively. For patients with adenocarcinoma who underwent curative resection, tumor (T) and node (N) stages were significant prognostic factors predicting overall survival. For patients with sarcomas who underwent curative resection, tumor grade was a significant prognostic factor predicting overall survival. The prognosis for patients with small intestinal carcinoid tumors is uniformly favorable. The prognosis for patients with sarcomas and adenocarcinomas is generally poor, although long-term survival is achieved by patients with favorable prognostic factors.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Jemal A, Murray T, Sammuels A, et al. Cancer Statistics, 2003. CA Cancer J Clin 2003;53:5–26.
American Joint Committee on Cancer. Small intestine. AJCC Cancer Staging Manual, 5th ed. Philadelphia: Lippincott-Raven, 1997, pp 77–81.
Veyrieres M, Baillet P, Hay JM, et al. Factors influencing long-term survival in 100 cases of small intestine primary adenocarcinoma. Am J Surg 1997;173:237–239.
Abrahams NA, Halverson A, Fazio VW, et al. Adenocarcinoma of the small bowel: A study of 37 cases with emphasis on histologic prognostic factors. Dis Colon Rectum 2002; 45:1496–1502.
Horowitz J, Spellman JE Jr, Driscoll DL, et al. An institutional review of sarcomas of the large and small intestine. J Am Coll Surg 1995;180:465–471.
Yao KA, Talamonti MS, Langella RL, et al. Primary gastrointestinal sarcomas: Analysis of prognostic factors and results of surgical management. Surgery 2000;128:604–612.
Conlon KC, Casper ES, Brennan MF. Primary gastrointestinal sarcomas: Analysis of prognostic variables. Ann Surg Oncol 1995;2:26–31.
Shebani KO, Souba WW, Finkelstein DM, et al. Prognosis and survival in patients with gastrointestinal tract carcinoid tumors. Ann Surg 1999;229:815–821; discussion 822–823.
Howe JR, Karnell LH, Menck HR, Scott-Conner C. The American College of Surgeons Commission on Cancer and the American Cancer Society. Adenocarcinoma of the small bowel: Review of the National Cancer Data Base, 1985–1995. Cancer 1999;86:2693–2706.
Singer S, Rubin BP, Lux ML, et al. Prognostic value of KIT mutation type, mitotic activity, and histologic subtype in gastrointestinal stromal tumors. J Clin Oncol 2002;20:3898–3905.
Demetri GD, von Mehren M, Blanke CD, et al. Efficacy and safety of imatinib mesylate in advanced gastrointestinal stromal tumors. N Engl J Med 2002;347:472–480.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Ito, H., Perez, A., Brooks, D.C. et al. Surgical treatment of small bowel cancer: A 20-year single institution experience. Journal of Gastrointestinal Surgery 7, 925–930 (2003). https://doi.org/10.1007/s11605-003-0042-8
Issue Date:
DOI: https://doi.org/10.1007/s11605-003-0042-8